BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Jerini AG 

Invalidenstrasse 130

Berlin    10115  Germany
Phone: 49-30-97893-0 Fax: 49-30-97893-105


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Start Up





 Company News
Jerini AG Reports First Quarter 2009 Financial Results 5/15/2009 2:39:28 PM    More...
Jerini AG Receives Request for Transfer of Minority Shareholders' Shares in Jerini AG to Shire Deutschland Investments GmbH 12/16/2008 12:01:19 PM    More...
Jerini AG Reports Financial Results for First Nine Months of 2008 11/14/2008 8:52:24 AM    More...
Jerini AG To Divest Jerini Ophthalmic, JPT Peptide Technologies GmbH, And Jerini's Pre-Clinical Projects 10/10/2008 7:36:12 AM    More...
Jerini AG's Management and Supervisory Boards Recommend That Jerini Shareholders Accept Shire Limited's Takeover Offer 8/25/2008 9:29:47 AM    More...
Jerini AG Reports Financial Results for First Half 2008 8/14/2008 9:30:46 AM    More...
Shire Limited Announces Holding of 81% in Jerini AG and Publication of Offer Document 8/13/2008 10:48:52 AM    More...
Jerini AG Receives European Commission Approval for FIRAZYR(R) (Icatibant) in the Treatment of HAE 7/15/2008 7:27:27 AM    More...
Shire Limited to Buy German Biotech Jerini AG for $518 Million 7/3/2008 6:40:15 AM    More...
Jerini AG to Submit Complete Response to the FDA for Icatibant in the Treatment of HAE 6/23/2008 1:54:58 PM    More...
123456